Publications by authors named "Hebing Zhou"

Claim this Profile
V
Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Yunching Lai, Xiaolei Chen, Hebing Zhou

Exp Ther Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory Study.
Feng-Qi Liu, Zhuo-Yu An, Li-Juan Cui, Meng-Yu Xiao, Ye-Jun Wu, He-Bing Zhou, Jian-Ying Zhou

Adv Sci (Weinh)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine plus venetoclax for maintenance treatment in intermediate‑to‑low‑risk acute myeloid leukemia: A comparative analysis of clinical outcomes in an observational cohort.
Danyang Zhang, Xiaomin Dong, Yue Zhang, Xiaolei Chen, Jiaoyan Qu, Hebing Zhou

Oncol Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective Analysis of Venetoclax Combined with Azacitidine Compared with "3+7" or Similar Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia].
Lu-Lu Wang, Juan Zhang, Yue Zhang, Yong Zhang, Xiao-Min Dong, Yun-Hui Zhou, He-Bing Zhou

Zhongguo Shi Yan Xue Ye Xue Za Zhi· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia.
Tingting Chen, Yue Zhang, Danyang Zhang, Hebing Zhou

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Hui Zhou, Hebing Zhou

Signal Transduct Target Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.
Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, He-Bing Zhou

EClinicalMedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Yuan Jian, Long Chang, Ming-Xia Shi, Ying Sun, Xiao-Xia Chu, He-Bing Zhou

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Zhongjun Xia, Yun Leng, Baijun Fang, Yang Liang, Wei Li, Jianfeng Zhou, Hebing Zhou

BMC Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy in Philadelphia chromosome‑positive acute lymphoblastic leukemia with pericardial invasion after transplantation: A case report.
Jing Yuan, Yong Zhang, Hebing Zhou, Sen Wang, Qiteng Liu

Oncol Lett· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[MiR-203a-5p Inhibits Multiple Myeloma Cell Proliferation and Cell Cycle Progression via Targeting ].
Yue Zhang, Ting-Ting Chen, He-Bing Zhou, Wen-Ming Chen

Zhongguo Shi Yan Xue Ye Xue Za Zhi· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis.
Tingting Chen, Juan Zhang, Yinying Wang, Hebing Zhou

Dis Markers· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.
Shan Chong, Peng Zhao, Rui-Bin Huang, Hu Zhou, Jia-Ning Zhang, Ze-Ping Zhou, He-Bing Zhou

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP.
Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, He-Bing Zhou

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Efficient Film-Forming Additive for High-Voltage Lithium-Nickel-Manganese Oxide Cathodes.
Zekai Ma, Huiyang Chen, Hebing Zhou, Lidan Xing, Weishan Li

ACS Omega· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China.
Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Hebing Zhou

Cancer Biol Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.
Peng Zhao, Ming Hou, Yi Liu, Hui-Xin Liu, Rui-Bin Huang, Hu Zhou, Ze-Ping Zhou, He-Bing Zhou

Platelets· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
Xiaomin Dong, Danyang Zhang, Juan Zhang, Xiaolei Chen, Yue Zhang, Xiaohuan Zhou, Hebing Zhou

Oncol Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data.
Ruo-Yun Gui, Qiu-Sha Huang, Xuan Cai, Jin Wu, Hui-Xin Liu, He-Bing Zhou

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative effects of L-asparaginase in acute myeloid leukemia.
Tingting Chen, Juan Zhang, Hui Zeng, Yue Zhang, Yong Zhang, Xiaohuan Zhou, Hebing Zhou

Exp Ther Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma.
Yue Zhang, Xiao-Lei Chen, Wen-Ming Chen, He-Bing Zhou

Biomed Res Int· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilizing a High-Voltage Lithium-Rich Layered Oxide Cathode with a Novel Electrolyte Additive.
Jianlian Lan, Qinfeng Zheng, Hebing Zhou, Jianhui Li, Lidan Xing

ACS Appl Mater Interfaces· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and Suppressing the Destructive Cobalt(II) Species in Graphite Interphase.
Kang Wang, Lidan Xing, Kang Xu, Hebing Zhou, Weishan Li

ACS Appl Mater Interfaces· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilizing LiCoO/Graphite at High Voltages with an Electrolyte Additive.
Suping Wu, Yilong Lin, Lidan Xing, Gengzhi Sun, Hebing Zhou

ACS Appl Mater Interfaces· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma.
Ying Tian, Yue Zhang, Wan-Qiu Zhu, Xiao-Lei Chen, He-Bing Zhou

Biomed Res Int· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis